Published in Eur J Clin Pharmacol on January 01, 1983
The role of human cytochrome P450 enzymes in the formation of 2-hydroxymetronidazole: CYP2A6 is the high affinity (low Km) catalyst. Drug Metab Dispos (2013) 0.82
Pharmacokinetic studies in infants using minimal-risk study designs. Curr Clin Pharmacol (2014) 0.77
Metronidazole excretion in human milk and its effect on the suckling neonate. Br J Clin Pharmacol (1988) 0.77
Plasma metronidazole concentrations after single and repeated vaginal pessary administration. Br J Clin Pharmacol (1991) 0.75
Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries. J Med Genet (2003) 1.92
Oral bioavailability of digoxin is enhanced by talinolol: evidence for involvement of intestinal P-glycoprotein. Clin Pharmacol Ther (2000) 1.61
Induction of P-glycoprotein by rifampin increases intestinal secretion of talinolol in human beings: a new type of drug/drug interaction. Clin Pharmacol Ther (2000) 1.27
Childhood asthma in four countries: a comparative survey. Int J Epidemiol (1994) 1.25
Overexpression of sialyltransferase CMP-sialic acid:Galbeta1,3GalNAc-R alpha6-Sialyltransferase is related to poor patient survival in human colorectal carcinomas. Cancer Res (2001) 1.11
Pharmacokinetics and therapeutic efficacy of metronidazole at different dosages. Int J Clin Pharmacol Biopharm (1978) 1.03
N-acetylation and debrisoquine type oxidation polymorphism in Caucasians--with reference to age and sex. Int J Clin Pharmacol Ther Toxicol (1990) 1.02
Genetic influences on baroreflex function in normal twins. Hypertension (2001) 1.01
Interaction between beta-adrenergic receptor stimulation and nitric oxide release on tissue perfusion and metabolism. J Clin Endocrinol Metab (2001) 1.00
Osmosensitive mechanisms contribute to the water drinking-induced pressor response in humans. Neurology (2005) 0.98
Effects of heat shock on the functional morphology of cell organelles observed by video-enhanced microscopy. Anat Rec (1999) 0.93
Polysaccharides isolated from plant cell cultures of Echinacea purpurea enhance the resistance of immunosuppressed mice against systemic infections with Candida albicans and Listeria monocytogenes. Int J Immunopharmacol (1993) 0.91
Reference tables for the intrasubject coefficient of variation in bioequivalence studies. Int J Clin Pharmacol Ther (1995) 0.85
Improved detection of bacterial central nervous system infections by use of a broad-range PCR assay. J Clin Microbiol (2014) 0.84
Investigation of the anti-inflammatory potential of Aloe vera gel (97.5%) in the ultraviolet erythema test. Skin Pharmacol Physiol (2008) 0.84
Molecular characterisation of linezolid resistance in two vancomycin-resistant (VanB) Enterococcus faecium isolates using Pyrosequencing. Eur J Clin Microbiol Infect Dis (2008) 0.83
Limited effect of systemic beta-blockade on sympathetic outflow. Hypertension (2001) 0.83
Mouse interferon-gamma in liposomes: pharmacokinetics, organ-distribution, and activation of spleen and liver macrophages in vivo. J Interferon Res (1989) 0.82
Anticholinergic properties of propiverine and its metabolites. Pharmazie (1990) 0.80
[Comparison of public health systems within the European Community]. Gesundheitswesen (1994) 0.80
Pharmacokinetics of Metronidazole in pregnant women. Chemotherapy (1981) 0.80
Placental transfer of metronidazole. J Perinat Med (1985) 0.78
Vancomycin minimal inhibitory concentration from broth microdilution and Etest in respiratory tract samples of patients with ventilation-associated pneumonia. J Hosp Infect (2010) 0.78
A two-dose schedule for immunization of infants against diphtheria, pertussis and tetanus. J Biol Stand (1980) 0.78
[Oncology patients in a pediatric intensive care unit--a 7-year experience]. Klin Padiatr (2003) 0.78
Genetic influences on the pharmacokinetics of orally and intravenously administered digoxin as exhibited by monozygotic twins. Clin Pharmacol Ther (2009) 0.78
Immunotherapy of murine visceral leishmaniasis with murine recombinant interferon-gamma and MTP-PE encapsulated in liposomes. J Interferon Res (1991) 0.77
N-Acetylation phenotyping with sulfamethazine--problems of sampling. Pharmazie (1989) 0.77
Kinetics of propiverine as assessed by radioreceptor assay in poor and extensive metabolizers of debrisoquine. Eur J Drug Metab Pharmacokinet (1994) 0.77
Comparison between human immunodeficiency virus positive and negative patients with tuberculosis in Southern Brazil. Mem Inst Oswaldo Cruz (1999) 0.77
Nocloprost, a unique prostaglandin E2 analog with local gastroprotective and ulcer-healing activity. Eur J Pharmacol (1991) 0.77
[Differential value of various vital stains of corneal endothelium]. Ophthalmologe (1995) 0.77
A new perfusion cell chamber system for determination of heat shock effects by means of video-enhanced microscopy. Med Biol Eng Comput (1999) 0.77
Oxidation phenotyping with debrisoquine in Germany (East). Pharmazie (1990) 0.77
N-acetylator phenotypes in hyperthyroidism. Int J Clin Pharmacol Ther Toxicol (1988) 0.77
[Biological testing of biomaterials in the framework of permitted procedures. 2]. Z Exp Chir Transplant Kunstliche Organe (1988) 0.77
[The occurrence of uterine rupture at the Universitäts-Frauenklinik Greifswald in the time between 1930 and 1966]. Zentralbl Gynakol (1967) 0.77
Tyramine in the assessment of regional adrenergic function. Biochem Pharmacol (2006) 0.77
The effect of oral glucose loads on tissue metabolism during angiotensin II receptor and beta-receptor blockade in obese hypertensive subjects. Horm Metab Res (2006) 0.76
Efficacy of crisis intervention treatment with topical corticosteroid prednicarbat with and without partial wet-wrap dressing in atopic dermatitis. Dermatology (2006) 0.76
Kidney transplantation improves quality of life. Transplant Proc (1997) 0.76
Bioavailability studies of calcium dobesilate--a case of flip-flop kinetics. Pharmazie (1985) 0.76
[Therapy of endometriosis with dienogest]. Zentralbl Gynakol (1987) 0.76
Familial arhinia, choanal atresia, and microphthalmia. Am J Med Genet (1996) 0.76
[Proceedings: Reconstruction of the human external ear in animal experiments]. Arch Klin Exp Ohren Nasen Kehlkopfheilkd (1973) 0.75
[Our experiences with regional skin flaps in the treatment of large defects of the head and neck region following tumor extirpation]. Arch Klin Exp Ohren Nasen Kehlkopfheilkd (1971) 0.75
N-acetylation and debrisoquine hydroxylation polymorphisms in patients with Gilbert's syndrome. Br J Clin Pharmacol (1991) 0.75
Hypothalamic neuropeptide release after experimental subarachnoid hemorrhage: in vivo microdialysis study. Acta Neurol Scand (2004) 0.75
Pharmacokinetic interactions between isoniazid and theophylline in rats. J Pharm Pharmacol (1992) 0.75
Reconstruction of a partial auricular loss. Case report. Plast Reconstr Surg (1972) 0.75
[Antibody response to hemagglutinin and neuraminidase induced by an influenza subunit vaccine (author's transl)]. Zentralbl Bakteriol Orig A (1979) 0.75
[Caffeine-stimulated lipolysis in relation to pathologic pregnancy]. Zentralbl Gynakol (1976) 0.75
[Use of medicinal plant extracts in accident therapy and in inflammation of joints and soft parts]. Landarzt (1965) 0.75
N-acetylation and oxidative capacity in aged volunteers determined with sulfamethazine and antipyrine. Int J Clin Pharmacol Ther Toxicol (1991) 0.75
[Recommendations of the Scientific Council 1968. X. Fewer medical students--more dental students]. Zahnarztl Mitt (1968) 0.75
[Orciprenaline in haemorrhagic shock (author's transl)]. Anaesthesist (1973) 0.75
Sublytic doses of streptolysin O-effects on the metabolic fate of procainamide in rats. Pharmazie (1991) 0.75
[Recommendations of the Scientific Council 1968. VII. Must statistics lie?]. Zahnarztl Mitt (1968) 0.75
[Classification of epidemiological studies of dental caries and definitions of related terms]. Int Dent J (1976) 0.75
Drug oxidation and N-acetylation in rats pretreated with subtoxic doses of streptolysin O. Biochem Pharmacol (1991) 0.75
[Recommendations of the Scientific council. XIV. The "front" has spoken]. Zahnarztl Mitt (1969) 0.75
[Interpretation and examples for Bugo-Z. IV. Prosthetic services]. Zahnarztl Mitt (1965) 0.75
[Recommendations of the Scientific Council 1968. With optimism toward the future]. Zahnarztl Mitt (1969) 0.75
[Recommendations for the handling of mercury]. Int Dent J (1978) 0.75
[Dental manpower in the German Federal Republic]. Dent Echo (Heidelb) (1973) 0.75
[Unilateral exophthalmos and arteriovenous aneurysm in the region of the Sylvian vessel group in an infant]. Klin Monbl Augenheilkd (1967) 0.75
[Recommendation of the Scientific Council 1968. V. All provinces must cooperate]. Zahnarztl Mitt (1968) 0.75
[Electronic data processing as an aid in occupational medicine documentation - methods, experiences, perspectives]. Zentralbl Arbeitsmed Arbeitsschutz Prophyl Ergonomie (1982) 0.75
A bioequivalence study on retarded formulations of carbamazepine tablets. Int J Clin Pharmacol Ther Toxicol (1992) 0.75
Pharmacokinetics of almitrine in healthy volunteers and patients with essential hypertension. Biomed Biochim Acta (1991) 0.75
[The treatment of deciduous teeth]. Zahnarztl Mitt (1968) 0.75
Bioavailability of metronidazole vaginal tablets (Vagimid). Int J Clin Pharmacol Ther Toxicol (1992) 0.75
[Study of the pharmacokinetics of morphocycline, tetraverine and oxytetracycline]. Farmakol Toksikol (1978) 0.75
[Recommendations of the scientific council 1968. XII. A wave of new highschool graduates is coming up]. Zahnarztl Mitt (1968) 0.75
Bioavailability of metronidazole formulations (Vagimid). Pharmazie (1992) 0.75
[20 years of Federal Association for Health Education]. Zahnarztl Mitt (1974) 0.75
[Recommendations for dental radiography methods]. Int Dent J (1978) 0.75
[Serum hyposomolarity, brain edema and the bulbar brain syndrome as complications in the course of severe cranio-cerebral injuries in children]. Anaesthesiol Reanim (1991) 0.75
Trichloroethylene vapours do not produce dominant lethal mutations in male mice. Arch Toxicol (1980) 0.75
[Recommendations of the Scientific Council 1968. 8. Teaching capacity]. Zahnarztl Mitt (1968) 0.75
[Recommendations of the Scientific Council 1968. 13. Model 100]. Zahnarztl Mitt (1968) 0.75
The estimation of drug plasma levels in epileptics. Int J Clin Pharmacol Biopharm (1978) 0.75
[Various practical comments on microorbital complications]. Cesk Stomatol (1979) 0.75
[Basic requirements for controlled clinical studies of periodontal diseases]. Int Dent J (1978) 0.75
Effects of isoniazid on hepatic drug oxidation and N-acetylation capacities in rats. Pharmazie (1992) 0.75
[New registrations insufficient]. Zahnarztl Mitt (1966) 0.75
[The wave of graduates is rolling]. Zahnarztl Mitt (1974) 0.75
[A documentation for the question of the new generation in dentistry]. Zahnarztl Mitt (1968) 0.75
[Recommendation of the Scientific Council 1968. IX. Association of German Dentists asks for coordination]. Zahnarztl Mitt (1968) 0.75
Problems in the kinetic evaluation of capacity-limited processes by means of the analog computer MEDA 82 T. Int J Clin Pharmacol Biopharm (1978) 0.75
[Enlargement of the sella in primary hypothyroidism]. Z Gesamte Inn Med (1981) 0.75
[Introduction of a model in industrial medicine--data utilization in occupational medicine]. Zentralbl Arbeitsmed Arbeitsschutz Prophyl Ergonomie (1980) 0.75
[Prognosis, chronification and therapeutic relations in unsatisfactorily improved secondary faulty developments with cardiovascular affections]. Psychiatr Neurol Med Psychol (Leipz) (1979) 0.75
[Interpretations and examples of Bugo-Z]. Zahnarztl Mitt (1965) 0.75
[On the question of the metabolic effect of Harongan in diabetes mellitus]. Ther Ggw (1966) 0.75
[Recommendations of the Scientific Council 1968. XI. It's a long way]. Zahnarztl Mitt (1968) 0.75